Use of substituted 2-imidazole of imidazoline derivatives

Details for Australian Patent Application No. 2007209381 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Groebke Zbinden, Katrin; Hoener, Marius; Norcross, Roger; Stalder, Henri; Galley, Guido; Kolczewski, Sabine

Agent Spruson & Ferguson

Pub. Number AU-A-2007209381

PCT Pub. Number WO2007/085557

Priority 06100955.1 27.01.06 EP

Filing date 17 January 2007

Wipo publication date 2 August 2007

International Classifications

A61K 31/4164 (2006.01) - 1,3-Diazoles

A61K 31/4174 (2006.01)

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

C07D 233/06 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

C07D 233/54 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 405/06 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 409/06 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

Event Publications

21 August 2008 PCT application entered the National Phase

  PCT publication WO2007/085557 Priority application(s): WO2007/085557

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007209382-Use of 2-imidazoles for the treatment of CNS disorders

2007209380-Use of 4-imidazole derivatives for CNS disorders